Keio University

World's First Successful Ex Vivo Resection and Autotransplantation of the Small Intestine for Postoperative Recurrence of Duodenal Cancer

Publish: July 04, 2017
Public Relations Office

July 4, 2017

Keio University Hospital

Professor Yuko Kitagawa and Senior Lecturer Taizo Hibi from the Department of Surgery (General and Gastroenterological) at the Keio University School of Medicine, together with Professor Tomoaki Kato from the Department of Surgery at Columbia University Medical Center, successfully performed the world's first ex vivo resection and autotransplantation for a postoperative recurrence of duodenal cancer caused by Peutz-Jeghers syndrome. The procedure, the first of its kind ever reported, was performed this February at Keio University Hospital on a 38-year-old male patient.

Because this surgical procedure requires complex surgical techniques involving the reconstruction of major blood vessels, it is extremely rare for it to be applied to recurrent lesions. Although the surgical indications will need to be considered very carefully on a case-by-case basis in the future, this is expected to become a new surgical strategy for lesions that are considered difficult or impossible to resect using conventional surgical methods.

Please see below for the full press release.

Press Release (PDF)